Invention Grant
- Patent Title: Polyclonal gamma delta T cells for immunotherapy
-
Application No.: US15031610Application Date: 2014-10-24
-
Publication No.: US09907820B2Publication Date: 2018-03-06
- Inventor: Laurence J. N. Cooper , Drew C. Deniger
- Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2014/062191 WO 20141024
- International Announcement: WO2015/061694 WO 20150430
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61K35/17 ; A61K39/00
Abstract:
Provided herein is a method of expanding clinically-relevant quantities of polyclonal γδ T cells that have anti-tumor, anti-viral, and anti-bacterial reactivity. Polyclonal γδ T cells can target a variety of tumors, including solid tumors as well as other conditions, such as viral and bacterial infections.
Public/Granted literature
- US20160256487A1 POLYCLONAL GAMMA DELTA T CELLS FOR IMMUNOTHERAPY Public/Granted day:2016-09-08
Information query
